BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 26424693)

  • 1. Comparison of nine prognostic scores in patients with brain metastases of breast cancer receiving radiotherapy of the brain.
    Laakmann E; Riecke K; Goy Y; Kersten JF; Krüll A; Müller V; Petersen C; Witzel I
    J Cancer Res Clin Oncol; 2016 Jan; 142(1):325-32. PubMed ID: 26424693
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Whole brain radiotherapy for brain metastases from breast cancer: estimation of survival using two stratification systems.
    Viani GA; Castilho MS; Salvajoli JV; Pellizzon AC; Novaes PE; Guimarães FS; Conte MA; Fogaroli RC
    BMC Cancer; 2007 Mar; 7():53. PubMed ID: 17386108
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Institutional, retrospective analysis of 777 patients with brain metastases: treatment outcomes and diagnosis-specific prognostic factors.
    Antoni D; Clavier JB; Pop M; Schumacher C; Lefebvre F; Noël G
    Int J Radiat Oncol Biol Phys; 2013 Jul; 86(4):630-7. PubMed ID: 23582409
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative performances of prognostic indexes for breast cancer patients presenting with brain metastases.
    Braccini AL; Azria D; Thezenas S; Romieu G; Ferreri JM; Jacot W
    BMC Cancer; 2013 Feb; 13():70. PubMed ID: 23394467
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Breast cancer patients with brain metastases or leptomeningeal disease: 10-year results of a national cohort with validation of prognostic indexes.
    Znidaric T; Gugic J; Marinko T; Gojkovic Horvat A; Paulin Kosir MS; Golo D; Ivanetic Pantar M; Ratosa I
    Breast J; 2019 Nov; 25(6):1117-1125. PubMed ID: 31286623
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Brain metastases from breast carcinoma: validation of the radiation therapy oncology group recursive partitioning analysis classification and proposition of a new prognostic score.
    Le Scodan R; Massard C; Mouret-Fourme E; Guinebretierre JM; Cohen-Solal C; De Lalande B; Moisson P; Breton-Callu C; Gardner M; Goupil A; Renody N; Floiras JL; Labib A
    Int J Radiat Oncol Biol Phys; 2007 Nov; 69(3):839-45. PubMed ID: 17544592
    [TBL] [Abstract][Full Text] [Related]  

  • 7. External validation of Modified Breast Graded Prognostic Assessment for breast cancer patients with brain metastases: A multicentric European experience.
    Griguolo G; Jacot W; Kantelhardt E; Dieci MV; Bourgier C; Thomssen C; Bailleux C; Miglietta F; Braccini AL; Conte P; Ferrero JM; Guarneri V; Darlix A
    Breast; 2018 Feb; 37():36-41. PubMed ID: 29073498
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic factors affecting the outcome of brain metastases from breast cancer.
    Liu MT; Hsieh CY; Wang AY; Chang TH; Pi CP; Huang CC; Huang CY; Liou CH
    Support Care Cancer; 2006 Sep; 14(9):936-42. PubMed ID: 16575571
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A new instrument for predicting survival of patients with cerebral metastases from breast cancer developed in a homogeneously treated cohort.
    Janssen S; Hansen HC; Dziggel L; Schild SE; Rades D
    Radiol Oncol; 2019 May; 53(2):219-224. PubMed ID: 31103998
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prediction of short survival in patients with brain metastases based on three different scores: a role for 'triple-negative' status?
    Nieder C; Pawinski A; Molls M
    Clin Oncol (R Coll Radiol); 2010 Feb; 22(1):65-9. PubMed ID: 19762219
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recursive partitioning analysis (RPA) class does not predict survival in patients with four or more brain metastases.
    Nieder C; Andratschke N; Grosu AL; Molls M
    Strahlenther Onkol; 2003 Jan; 179(1):16-20. PubMed ID: 12540980
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic indices in stereotactic radiotherapy of brain metastases of non-small cell lung cancer.
    Kaul D; Angelidis A; Budach V; Ghadjar P; Kufeld M; Badakhshi H
    Radiat Oncol; 2015 Nov; 10():244. PubMed ID: 26611493
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systemic treatment after whole-brain radiotherapy may improve survival in RPA class II/III breast cancer patients with brain metastasis.
    Zhang Q; Chen J; Yu X; Ma J; Cai G; Yang Z; Cao L; Chen X; Guo X; Chen J
    J Neurooncol; 2013 Sep; 114(2):181-9. PubMed ID: 23743596
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The clinical utility of prognostic scoring systems in patients with brain metastases treated with radiosurgery.
    Zindler JD; Rodrigues G; Haasbeek CJ; De Haan PF; Meijer OW; Slotman BJ; Lagerwaard FJ
    Radiother Oncol; 2013 Mar; 106(3):370-4. PubMed ID: 23522151
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic factors and grading systems for overall survival in patients treated with radiosurgery for brain metastases: variation by primary site.
    Golden DW; Lamborn KR; McDermott MW; Kunwar S; Wara WM; Nakamura JL; Sneed PK
    J Neurosurg; 2008 Dec; 109 Suppl():77-86. PubMed ID: 19123892
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic factors for survival in patients treated with stereotactic radiosurgery for recurrent brain metastases after prior whole brain radiotherapy.
    Caballero JA; Sneed PK; Lamborn KR; Ma L; Denduluri S; Nakamura JL; Barani IJ; McDermott MW
    Int J Radiat Oncol Biol Phys; 2012 May; 83(1):303-9. PubMed ID: 22079723
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of Survival of Patients with Brain Metastases According to Prognostic Indexes and Treatment Strategies.
    Saginc H; Baltalarli PB; Sagtas E; Coskun ME
    Turk Neurosurg; 2020; 30(6):822-831. PubMed ID: 32091122
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Validation of Modified Breast Graded Prognostic Assessment for breast cancer patients with brain metastases: extra-cranial disease progression is an independent risk factor.
    Zhuang Q; Wong RX; Lian WX; Li YQ; Wong FY
    Ann Palliat Med; 2019 Sep; 8(4):390-400. PubMed ID: 30943738
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic indexes for brain metastases: which is the most powerful?
    Viani GA; da Silva LG; Stefano EJ
    Int J Radiat Oncol Biol Phys; 2012 Jul; 83(3):e325-30. PubMed ID: 22633551
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A new scoring system to predicting the survival of patients treated with whole-brain radiotherapy for brain metastases.
    Rades D; Dunst J; Schild SE
    Strahlenther Onkol; 2008 May; 184(5):251-5. PubMed ID: 18427755
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.